Publications by authors named "Mike Hamblin"

Claim this Profile
I
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Jacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, Neil E Kay, Nishitha M Reddy, Mike Hamblin

Clin Lymphoma Myeloma Leuk· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia.
Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison, Mike Hamblin

Blood Adv· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.
Claire E Dearden, Amit Khot, Monica Else, Mike Hamblin, Effie Grand

Blood· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis